Baxano, Inc., based in San Jose, California, is a privately held company, founded in 2005.
Baxano’s mission is to develop and market innovative tools that restore spine function, preserve healthy tissue, and enable a better quality of life for the patients it serves. Along with its dedication to advanced technology development, Baxano is focused on providing exceptional value to patients, customers, investors, and employees.
The iO-Flex® System, Baxano’s flagship device, commercialized in 2009, is the first minimally invasive set of flexible instruments allowing surgeons to target lumbar spinal stenosis in all three regions of the spine: central canal, lateral recess, and neural foramen.
In addition, the system allows for minimal disruption to the patient’s healthy anatomy which is critical for maintaining spinal stability. Decompression surgery (laminectomy/laminotomy) with or without spinal fusion is a common procedure used to treat lumbar spinal stenosis by cutting away overgrown bone and tissue which causes pressure on the spinal nerves.
In 2012 Baxano expanded its product offering with a second FDA-cleared device, the iO-Tome®. The iO-Tome® instrument utilizes the iO-Flex® platform to deliver a new MicroBlade Shaver® design configured to rapidly and precisely remove bone, including the facet joints, which is commonly performed in spinal fusion procedures.